- Home
- LTC vs SPRY Comparison
LTC vs SPRY Comparison
Compare LTC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- SPRY
- Stock Information
- Founded
- LTC 1992
- SPRY 2015
- Country
- LTC United States
- SPRY United States
- Employees
- LTC N/A
- SPRY N/A
- Industry
- LTC Real Estate Investment Trusts
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- LTC Real Estate
- SPRY Health Care
- Exchange
- LTC Nasdaq
- SPRY Nasdaq
- Market Cap
- LTC 1.7B
- SPRY 1.8B
- IPO Year
- LTC 1992
- SPRY N/A
- Fundamental
- Price
- LTC $34.83
- SPRY $10.37
- Analyst Decision
- LTC Hold
- SPRY Strong Buy
- Analyst Count
- LTC 5
- SPRY 5
- Target Price
- LTC $38.80
- SPRY $31.00
- AVG Volume (30 Days)
- LTC 401.5K
- SPRY 2.8M
- Earning Date
- LTC 10-27-2025
- SPRY 11-12-2025
- Dividend Yield
- LTC 6.53%
- SPRY N/A
- EPS Growth
- LTC N/A
- SPRY N/A
- EPS
- LTC 1.81
- SPRY N/A
- Revenue
- LTC $213,197,000.00
- SPRY $112,339,000.00
- Revenue This Year
- LTC N/A
- SPRY N/A
- Revenue Next Year
- LTC N/A
- SPRY $188.92
- P/E Ratio
- LTC $19.33
- SPRY N/A
- Revenue Growth
- LTC 8.74
- SPRY 22367.80
- 52 Week Low
- LTC $31.70
- SPRY $9.34
- 52 Week High
- LTC $39.89
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- LTC 37.01
- SPRY 42.23
- Support Level
- LTC $36.21
- SPRY $9.72
- Resistance Level
- LTC $37.25
- SPRY $11.03
- Average True Range (ATR)
- LTC 0.61
- SPRY 0.56
- MACD
- LTC -0.13
- SPRY 0.27
- Stochastic Oscillator
- LTC 11.73
- SPRY 57.23
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.